Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial sponsored by Yale University is evaluating epigallocatechin gallate (EGCG) from green tea for treating uterine fibroids and unexplained…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epigallocatechin Gallate (epigallocatechin gallate)

Snippet

Sponsor: Yale University | Conditions: Leiomyoma, Uterine | Phase 3 | Status: ACTIVE_NOT_RECRUITING